Abstract P065: Effects of Palm Oil Consumption on Blood Lipids: A Meta-Analysis of Clinical Trials

Circulation ◽  
2014 ◽  
Vol 129 (suppl_1) ◽  
Author(s):  
Ye Sun ◽  
Nithya Neelakantan ◽  
Yi Wu ◽  
Rob M van Dam
Keyword(s):  
Total Cholesterol ◽  
Vegetable Oils ◽  
Palm Oil ◽  
Ldl Cholesterol ◽  
Meta Analysis ◽  
Geographical Location ◽  
Hdl Cholesterol ◽  
Oil Consumption ◽  
Animal Fats ◽  
Study Results

Introduction: Palm oil is among the most commonly consumed cooking oils worldwide and, in contrast to most other vegetable oils, contains a high amount of saturated fatty acids. It has been suggested that palm oil has unique characteristics resulting in less detrimental effects on blood lipids than expected from its fat content. We therefore evaluated the effect of palm oil consumption on blood lipid concentrations as compared with vegetable oils high in natural unsaturated fatty acids, partially hydrogenated vegetable oils (rich in trans -fat), or animal fats. Methods: We searched PubMed, the Cochrane Library, Scopus, ProQuest, and Web of Science databases up to 31 October 2012 for trials of at least 2 weeks that compared the effects of palm oil consumption with at least one of the aforementioned comparison oils. Data on effects on total, LDL and HDL cholesterols and triglycerides were pooled using random effects meta-analysis. Results: A total of 25 studies were identified comparing palm oil with natural highly unsaturated vegetable oils. Palm oil significantly increased total cholesterol by 0.32 mmol/L (95% CI: 0.19, 0.44; I 2 =85.9%), increased LDL cholesterol by 0.20 mmol/L (95% CI: 0.09, 0.32; I 2 =82.9%), and increased HDL cholesterol by 0.02 mmol/L (95% CI: 0.01, 0.04; I 2 =56%) as compared with control oils. The considerable amount of heterogeneity in study results were partly explained by the type of control oil used, funding source, geographical location, and level of intake of test oil. Statistical tests suggested that this meta-analysis might be subject to publication bias. Eight studies were identified comparing palm oil with partially hydrogenated vegetable oils. When compared to trans -fat rich oils, palm oil significantly increased HDL cholesterol by 0.07 mmol/L (95% CI: 0.05, 0.09; I 2 =19.2%). However, palm oil did not significantly change total cholesterol (0.15 mmol/L, 95% CI: -0.04, 0.33), LDL cholesterol (0.11 mmol/L, 95% CI: -0.04, 0.27), or triglycerides (-0.02 mmol/L, 95% CI: -0.12, 0.07). Geographical location, method of preparation of test oils, and level of intake of trans -fat in control intervention were contributors to the heterogeneity in the study results. The pooled results from the 2 studies on comparison between palm oil and animal fats did not show a significant difference between the two dietary groups for total cholesterol (0.00 mmol/L, 95% CI: -0.08, 0.08), LDL cholesterol (-0.01 mmol/L, 95% CI: -0.08, 0.07), HDL cholesterol (0.00 mmol/L, 95% CI: -0.03, 0.04), or triglycerides (0.02 mmol/L, 95% CI: -0.15, 0.17). Conclusions: Palm oil consumption results in higher LDL cholesterol levels than other natural unsaturated vegetable oils. However, palm oil may be preferable to trans -fat rich oils based on its effect on HDL cholesterol. More studies are needed to evaluate the effects of palm oil consumption on incidence of coronary heart diseases.

The latest research on coconut oil and human health

2021 ◽  
Vol 32 (10) ◽  
pp. 28-29
Author(s):  
Rebecca Guenard ◽  
Keyword(s):  
Clinical Trials ◽  
Total Cholesterol ◽  
Ldl Cholesterol ◽  
Meta Analysis ◽  
Coconut Oil ◽  
Hdl Cholesterol ◽  
Blood Lipid ◽  
Oil Consumption ◽  
Controlled Clinical Trials ◽  
Human Adults

A meta-analysis of clinical trials comparing the effects of coconut oil consumption with other fats focused only on controlled clinical trials performed on human adults with a duration exceeding two weeks (long enough to let blood lipid concentrations stabilize).coconut oil consumption significantly increased total cholesterol, LDL-cholesterol, and HDL-cholesterol concentrations compared with non-tropical vegetable oils and significantly increased total cholesterol and LDL-cholesterol concentrations compared with palm oil.

scholarly journals Palm Oil Consumption Increases LDL Cholesterol Compared with Vegetable Oils Low in Saturated Fat in a Meta-Analysis of Clinical Trials

2015 ◽  
Vol 145 (7) ◽  
pp. 1549-1558 ◽  
Author(s):  
Ye Sun ◽  
Nithya Neelakantan ◽  
Yi Wu ◽  
Rashmi Lote-Oke ◽  
An Pan ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Vegetable Oils ◽  
Palm Oil ◽  
Ldl Cholesterol ◽  
Meta Analysis ◽  
Saturated Fat ◽  
Oil Consumption

Effects of diacerein intake on cardiometabolic profiles in type 2 diabetics: a systematic review and meta-analysis of clinical trials.

2020 ◽  
Vol 27 ◽  
Author(s):  
Peyman Nowrouzi-Sohrabi ◽  
Reza Tabrizi ◽  
Mohammad Jalali ◽  
Navid Jamali ◽  
Shahla Rezaei ◽  
...  
Keyword(s):  
Systematic Review ◽  
Clinical Trials ◽  
Body Weight ◽  
Total Cholesterol ◽  
Ldl Cholesterol ◽  
Meta Analysis ◽  
Hdl Cholesterol ◽  
Cochrane Central Register ◽  
Statistical Heterogeneity

Introduction: A systematic review and meta-analysis of clinical trials was undertaken to evaluate the effect of diacerein intake on cardiometabolic profiles in patients with type 2 diabetes mellitus (T2DM). Methods: Electronic databases such as PubMed, EMBASE, Scopus, Web of Science, Google Scholar, and Cochrane Central Register of Controlled Trials were searched from inception to 31 July 2019. Statistical heterogeneity was evaluated using Cochran’s Q test and I-square (I2 ) statistic. Data were pooled using random-effect models and weighted mean difference (WMD). Results: From 1,733 citations, seven clinical trials were eligible for inclusion and meta-analysis. A significant reduction in hemoglobin A1c (HbA1c) (WMD -0.73; 95%CI -1.25 to -0.21; P= 0.006; I2 = 72.2%) and body mass index (BMI) (WMD -0.55; 95%CI -1.03 to -0.07; P= 0.026; I2 = 9.5%) were identified. However, no significant effect of diacerein intake was identified on fasting blood sugar (FBS) (WMD - 9.00; 95%CI -22.57 to 4.57; P= 0.194; I2 = 60.5%), homeostatic model assessment for insulin resistance (HOMA-IR) (WMD 0.39; 95%CI 0.95 to 1.73; P= 0.569; I2 = 2.2%), body weight (WMD -0.54; 95%CI -1.10 to 0.02; P= 0.059), triglycerides (WMD -0.56; 95%CI -24.16 to 23.03; P= 0.963; I2 = 0.0%), total-cholesterol (WMD -0.21; 95%CI -12.19 to 11.78; P= 0.973; I2 = 0.0%), HDL-cholesterol (WMD -0.96; 95%CI -2.85 to 0.93; P= 0.321; I2 = 0.0%), and LDL-cholesterol levels (WMD -0.09; 95%CI -8.43 to 8.25; P= 0.983; I2 = 37.8%). Conclusion: Diacerein intake may reduce HbA1c and BMI; however, no evidence of effect was observed for FBS, HOMA-IR, body weight, triglycerides, total-cholesterol, HDL-cholesterol or LDL-cholesterol.

scholarly journals Replacing Saturated Fats with Unsaturated Fats from Walnuts or Vegetable Oils Lowers Atherogenic Lipoprotein Classes Without Increasing Lipoprotein(a)

2020 ◽  
Vol 150 (4) ◽  
pp. 818-825 ◽  
Author(s):  
Alyssa M Tindall ◽  
Penny M Kris-Etherton ◽  
Kristina S Petersen
Keyword(s):  
At Risk ◽  
Total Cholesterol ◽  
Vegetable Oils ◽  
Mixed Models ◽  
Cholesterol Efflux ◽  
Ldl Cholesterol ◽  
Hdl Cholesterol ◽  
Lipoprotein A ◽  
Lipoprotein Subclasses ◽  
Feeding Study

ABSTRACT Background Walnuts have established lipid-/lipoprotein-lowering properties; however, their effect on lipoprotein subclasses has not been investigated. Furthermore, the mechanisms by which walnuts improve lipid/lipoprotein concentrations are incompletely understood. Objectives We aimed to examine, as exploratory outcomes of this trial, the effect of replacing SFAs with unsaturated fats from walnuts or vegetable oils on lipoprotein subclasses, cholesterol efflux, and proprotein convertase subtilisin/kexin type 9 (PCSK9). Methods A randomized, crossover, controlled-feeding study was conducted in individuals at risk of cardiovascular disease (CVD) (n = 34; 62% men; mean ± SD age 44 ± 10 y; BMI: 30.1 ± 4.9 kg/m2). After a 2-wk run-in diet (12% SFAs, 7% PUFAs, 12% MUFAs), subjects consumed the following diets, in randomized order, for 6 wk: 1) walnut diet (WD) [57–99 g/d walnuts, 7% SFAs, 16% PUFAs [2.7% α-linolenic acid (ALA)], 9% MUFAs]; 2) walnut fatty acid–matched diet [7% SFAs, 16% PUFAs (2.6% ALA), 9% MUFAs]; and 3) oleic acid replaces ALA diet (ORAD) [7% SFAs, 14% PUFAs (0.4% ALA); 12% MUFAs] (all percentages listed are of total kilocalories ). Serum collected after the run-in (baseline) and each diet period was analyzed for lipoprotein classes and subclasses (vertical auto profile), cholesterol efflux, and PCSK9. Linear mixed models were used for data analysis. Results Compared with the ORAD, total cholesterol (mean ± SEM −8.9± 2.3 mg/dL; −5.1%; P < 0.001), non-HDL cholesterol (−7.4 ± 2.0 mg/dL; −5.4%; P = 0.001), and LDL cholesterol (−6.9 ± 1.9 mg/dL; −6.5%; P = 0.001) were lower after the WD; no other pairwise differences existed. There were no between-diet differences for HDL-cholesterol or LDL-cholesterol subclasses. Lipoprotein(a) [Lp(a)], cholesterol efflux, and PCSK9 were unchanged after the diets. Conclusions In individuals at risk of CVD, replacement of SFAs with unsaturated fats from walnuts or vegetable oils improved lipid/lipoprotein classes, including LDL-cholesterol, non-HDL cholesterol, and total cholesterol, without an increase in Lp(a). These improvements were not explained by changes in cholesterol efflux capacity or PCSK9. This trial was registered at clinicaltrials.gov as NCT01235832.

scholarly journals Meta-analysis of the health effects of using the glycaemic index in meal-planning

2004 ◽  
Vol 92 (3) ◽  
pp. 367-381 ◽  
Author(s):  
A. Maretha Opperman ◽  
Christina S. Venter ◽  
Welma Oosthuizen ◽  
Rachel L. Thompson ◽  
Hester H. Vorster
Keyword(s):  
Lipid Metabolism ◽  
Total Cholesterol ◽  
Ldl Cholesterol ◽  
Meta Analysis ◽  
Scientific Evidence ◽  
Hdl Cholesterol ◽  
Glycaemic Index ◽  
Mean Values ◽  
Mortality And Morbidity ◽  
Carbohydrate And Lipid Metabolism

Diabetes mellitus and CVD are some of the leading causes of mortality and morbidity. Accumulating data indicate that a diet characterised by low-glycaemic index (GI) foods may improve the management of diabetes or lipid profiles. The objective of the present meta-analysis was to critically analyse the scientific evidence that low-GI diets have beneficial effects on carbohydrate and lipid metabolism compared with high-GI diets. We searched for randomised controlled trials with a crossover or parallel design published in English between 1981 and 2003, investigating the effect of low-GI v. high-GI diets on markers for carbohydrate and lipid metabolism. Unstandardised differences in mean values were examined using the random effects model. The main outcomes were fructosamine, glycated Hb (HbA1c), HDL-cholesterol, LDL-cholesterol, total cholesterol and triacylglycerol. Literature searches identified sixteen studies that met the strict inclusion criteria. Low-GI diets significantly reduced fructosamine by –0·1 (95 % CI –0·20, 0·00) mmol/l (P=0·05), HbA1c by 0·27 (95 % CI –0·5, –0·03) % (P=0·03), total cholesterol by –0·33 (95 % CI –0·47, –0·18) mmol/l (P>0·0001) and tended to reduce LDL-cholesterol in type 2 diabetic subjects by –0·15 (95 % CI –0·31, –0·00) mmol/l (P=0·06) compared with high-GI diets. No changes were observed in HDL-cholesterol and triacylglycerol concentrations. No substantial heterogeneity was detected, suggesting that the effects of low-GI diets in these studies were uniform. Results of the present meta-analysis support the use of the GI as a scientifically based tool to enable selection of carbohydrate-containing foods to reduce total cholesterol and to improve overall metabolic control of diabetes.

Abstract MP66: Cheese Consumption and Blood Lipids; a Systematic Review and Meta-analysis of Randomized Controlled Trials

Circulation ◽  
2014 ◽  
Vol 129 (suppl_1) ◽  
Author(s):  
Janette de Goede ◽  
Johanna M Geleijnse ◽  
Eric L Ding ◽  
Sabita S. Soedamah-Muthu
Keyword(s):  
Total Cholesterol ◽  
Blood Lipids ◽  
Ldl Cholesterol ◽  
Meta Analysis ◽  
Hdl Cholesterol ◽  
Fat Content ◽  
Control Treatment ◽  
Controlled Trials ◽  
Randomized Controlled ◽  
Lipids And Lipoproteins

Aims: Cheese may have a different effect on lipids and lipoproteins than expected from the saturated fat content. We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) to examine the effect of cheese consumption on blood lipids and lipoproteins in healthy populations. Methods: A systematic search in MEDLINE, EMBASE, Scopus, Cababstracts, Cochrane Controlled Trials Register, Clinicaltrials.gov was performed to identify RCTs of cheese supplementation in human adults with total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides as a primary or secondary outcome (published until September 2013). A quantitative meta-analysis was performed if more than four RCTs with a comparable control treatment were available. Within person-differences of lipids with corresponding standard errors caused by the cheese compared to the control treatment were pooled (random effects model, STATA 11.0). Results: We identified 15 RCTs, published between 1978 and 2012. We pooled four RCTs comparing the effect of cheese intake to butter with a similar fat content on plasma levels of total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides. The amount of cheese used in these trials was rather large, ranging between 120 and 205 g/d. This is approximately equivalent to 3 to 5 cheese servings per day. Intake of cheese (weighted mean difference: 142.6 g/d) reduced total cholesterol significantly by -0.27 mmol/l (95% CI: -0.36 to -0.18), LDL-C by -0.21 mmol/l (95% CI: -0.29 to -0.13), and HDL-C by -0.05 (95% CI: -0.08 to -0.02) compared to butter. The pooled effect on triglycerides was 0.004 (95% CI: -0.058 to 0.065). No heterogeneity was observed (all I 2 =0%). Cheese was also compared with tofu (n=4 RCTs), fat-modified cheese (n=3), CLA-rich cheese (n=3), milk (n=2), fish (n=1), egg white (n=1). Trials that compared cheese with tofu or fat-modified cheese suggest that differential effects of the products can mainly be attributed to the differences in fatty acid content of the diets. Comparisons with CLA-rich cheese were of limited value because those studied the effects of CLA (and not cheese). Too few trials with milk, egg white, and fish were available to draw conclusions. Conclusions: Based on a limited number of trials, cheese appears less hypercholesterolemic than butter with a similar fat content. Differences in plasma lipids based on cheese compared with tofu and fat-modified products are likely to be caused by the different fat content of the total diets.

Effect of vitamin D supplementation on serum lipid profiles: a systematic review and meta-analysis

2019 ◽  
Vol 77 (12) ◽  
pp. 890-902 ◽  
Author(s):  
Daniel T Dibaba
Keyword(s):  
Vitamin D ◽  
Total Cholesterol ◽  
Serum Lipid ◽  
Ldl Cholesterol ◽  
Meta Analysis ◽  
Density Lipoprotein ◽  
Hdl Cholesterol ◽  
Vitamin D Supplementation ◽  
Lipid Profiles

Abstract Context Vitamin D deficiency is highly prevalent across the world. The existing evidence suggests vitamin D may have beneficial effects on serum lipid profiles and thus cardiovascular health. Objective The objective of this systematic review and meta-analysis was to examine the effect of vitamin D supplementation on serum lipid profiles. Data Source Original randomized controlled trials (RCTs) examining the effect of vitamin D supplementation on serum lipid profiles and published before July 2018 were identified by searching online databases, including PubMed, Google Scholar, and ScienceDirect, using a combination of relevant keywords. Data Extraction Data on study characteristics, effect size, measure of variation, type of vitamin D supplementation, and duration of follow-up were extracted by the author. Data Analysis PRISMA guidelines for systematic reviews were followed. Random effects (DerSimonian and Laird [D-V)] models were used to pool standardized mean differences in total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides between the active and the placebo arms of RCT studies. Between-study heterogeneities were assessed using Cochrane Q and I2, and publication bias was assessed using Begg’s test, Egger’s test, and funnel plot. Results A total of 41 RCTs comprising 3434 participants (n = 1699 in the vitamin D supplementation arm and n = 1735 in the placebo arm) were identified and included in the meta-analysis. Approximately 63.4% of study participants were women, with 14 studies conducted entirely among women. Approximately 24% of the trials had follow-up duration >6 months, whereas the remaining 76% had follow-up duration of <6 months. The standardized mean differences (SMDs) and 95% confidence intervals (CIs) for comparing the change from baseline to follow-up between the vitamin D supplementation arm and the placebo (control) arm were as follows: total cholesterol = –0.17 (–0.28 to –0.06); LDL cholesterol = –0.12 (–0.23 to –0.01); triglycerides = –0.12 (–0.25 to 0.01); and HDL cholesterol = –0.19 (–0.44 to 0.06). After removing a trial that was an outlier based on the magnitude of the effect size, the SMD for triglycerides was –0.15 (–0.24 to –0.06) and that for HDL cholesterol was –0.10 (–0.28 to 0.09). The improvements in total cholesterol and triglycerides were more pronounced in participants with baseline vitamin D deficiency. Conclusions Vitamin D supplementation appeared to have a beneficial effect on reducing serum total cholesterol, LDL cholesterol, and triglyceride levels but not HDL cholesterol levels. Vitamin D supplementation may be useful in hypercholesterolemia patients with vitamin D insufficiency who are at high risk of cardiovascular diseases.

scholarly journals Prévalence À L’obésité Par La Consommation Modérée D’huile De Palme Chez Le Rat

2016 ◽  
Vol 12 (30) ◽  
pp. 224
Author(s):  
Alex Innocent Hollywale Bohué ◽  
Adama Kamagaté ◽  
Angoué Paul Yapo
Keyword(s):  
Energy Balance ◽  
Food Intake ◽  
Total Cholesterol ◽  
Palm Oil ◽  
Ldl Cholesterol ◽  
Hdl Cholesterol ◽  
Cholesterol Levels ◽  
Food Content ◽  
Massive Accumulation ◽  
Refined Palm Oil

Palm oil is a vegetable oil extracted from the pulp of the palm oil fruit. It comes in crude or refined form. It is an oil which caused controversy due to lack of enough information on its use. Our study has shown that moderate consumption of palm oil, that do not exceed 15% of food content, over 28 days does not cause a significant increase in body mass in young rats. Similarly, the lack of significance in the indices of food intake, digestibility, protein efficiency and energy balance, among control and experimental groups of the rats confirmed that palm oil is good for nutrition when its consumption is moderate. However, our study showed that moderate consumption of palm oil does not affect the total cholesterol, HDL-cholesterol and LDL-cholesterol levels in young. While, moderate consumption of crude palm showed a significant increase in triglyceride rates but refined palm oil does not increase significantly triglyceride rates. Finally, our study showed that moderate consumption of palm oil does not cause a massive accumulation of the oil in the liver. This leads to say that palm oil is not the matter, but the way of consuming palm oil that could be a risk of metabolic syndromes.

scholarly journals Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis

2017 ◽  
Vol 211 (6) ◽  
pp. 339-349 ◽  
Author(s):  
Toby Pillinger ◽  
Katherine Beck ◽  
Brendon Stubbs ◽  
Oliver D. Howes
Keyword(s):  
Total Cholesterol ◽  
Ldl Cholesterol ◽  
Meta Analysis ◽  
Density Lipoprotein ◽  
Hdl Cholesterol ◽  
First Episode Psychosis ◽  
First Episode ◽  
Absolute Increase ◽  
Cholesterol Levels ◽  
Episode Psychosis

BackgroundThe extent of metabolic and lipid changes in first-episode psychosis (FEP) is unclear.AimsTo investigate whether individuals with FEP and no or minimal antipsychotic exposure show lipid and adipocytokine abnormalities compared with healthy controls.MethodWe conducted a meta-analysis of studies examining lipid and adipocytokine parameters in individuals with FEP and no or minimal antipsychotic exposurev.a healthy control group. Studies reported fasting total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides and leptin levels.ResultsOf 2070 citations retrieved, 20 case–control studies met inclusion criteria including 1167 patients and 1184 controls. Total cholesterol and LDL cholesterol levels were significantly decreased in patientsv.controls, corresponding to an absolute reduction of 0.26mmol/L and 0.15mmol/L respectively. Triglyceride levels were significantly increased in the patient group, corresponding to an absolute increase of 0.08 mmol/L However, HDL cholesterol and leptin levels were not altered in patientsv.controls.ConclusionsTotal and LDL cholesterol levels are reduced in FEP, indicating that hypercholesterolaemia in patients with chronic disorder is secondary and potentially modifiable. In contrast, triglycerides are elevated in FEP. Hypertriglyceridaemia is a feature of type 2 diabetes mellitus, therefore this finding adds to the evidence for glucose dysregulation in this cohort. These findings support early intervention targeting nutrition, physical activity and appropriate antipsychotic prescription.

scholarly journals PENGARUH DIET EMULSI VIRGIN COCONUT OIL (VCO) TERHADAP PROFIL LIPID TIKUS PUTIH (Rattus norvegicus)

2020 ◽  
Vol 17 (1) ◽  
pp. 18
Author(s):  
FETI FATIMAH ◽  
BARLINA RINDENGAN
Keyword(s):  
Lipid Profile ◽  
Total Cholesterol ◽  
Rattus Norvegicus ◽  
Ldl Cholesterol ◽  
Coconut Oil ◽  
Hdl Cholesterol ◽  
Virgin Coconut Oil ◽  
Group I ◽  
Study Results ◽  
Pap Method

<p>ABSTRAK</p><p>Virgin Coconut Oil (VCO) merupakan salah satu produk panganfungsional yang populer di masyarakat. Cita rasa VCO dapat diperkayadalam bentuk emulsi mengandung sari buah nenas. Penelitian inidilakukan untuk mengetahui pengaruh diet emulsi VCO terhadap profillipid tikus (Rattus norvegicus) yang sebelumnya diinduksi hiperlipidemiadengan lemak babi 180g/100g ransum dan kuning telur bebek dengandosis 4 ml/hari. Penelitian dilakukan bulan Januari sampai Desember 2009di Laboratorium Balai Penelitian Tanaman Kelapa dan Palma Lain(BALITKA), Laboratorium FMIPA Universitas Sam Ratulangi Manado,Laboratorium UPHP (Unit Penelitian Hewan Percobaan) UniversitasGadjah Mada Yogyakarta serta Laboratorium PAU IPB Bogor. Delapanbelas tikus dibagi secara acak ke dalam 3 kelompok (6 tikus perkelompok). Kelompok I adalah kelompok kontrol yang diberi akuades,kelompok II diberi diet emulsi VCO, dan kelompok III diberi diet VCOmurni. Kandungan kolesterol total, HDL, LDL, dan triasilgliserol diukursetelah akhir perlakuan dengan metode enzimatik. Kadar kolesterol totaldiukur menggunakan metode CHOD-PAP, kadar kolesterol LDLmenggunakan metode PVS, kadar kolesterol HDL menggunakan metodeCHOD-PAP dan kadar triasil gliserol menggunakan metode GPO-PAP.Hasil penelitian menunjukkan bahwa konsumsi 0,945ml/hari VCO dan3,78ml/hari emulsi VCO selama 7 hari dapat menurunkan kadar kolesteroltotal, kadar kolesterol LDL, serta meningkatkan kadar kolesterol HDLdarah tikus Wistar secara signifikan (=0,05), sedangkan penurunan kadartriasilgliserol hanya ditunjukkan oleh konsumsi emulsi VCO (=0,05).Dengan demikian, emulsi VCO yang diperkaya dengan sari buah nenasberperan lebih baik dari VCO murni dalam menurunkan kolesterol padahewan uji tikus.</p><p>Kata kunci: Virgin coconut oil (VCO), emulsi VCO, profil lemak</p><p>ABSTRACT</p><p>Effect of Virgin Coconut Oil (VCO) Emulsion Diet onLipid Profile of White Rats (Rattus norvegicus)</p><p>Virgin Coconut Oil (VCO) is a functional food product that ispopular in the society. VCO-emulsion is a VCO emulsified with pineapplejuice. This study was conducted to find out the effect of VCO-emulsiondiet on lipid profile of mouse (Rattus norvegicus) strain wistar which wasalready treated by inducting hyperlipidemia using lard (180g/100g) andyolk (4ml/days). This research was conducted from January to December2009 at the Laboratory of Coconut and Other Palm Trees ResearchInstitute (BALITKA), the Laboratory of FMIPA Sam Ratulangi UniversityManado, the Laboratory of Experiment Animal Research Unit GadjahMada University Yogyakarta, and the Laboratory of PAU IPB Bogor.Eighteen mice were randomly divided into 3 groups. Group I was thecontrol group treated with aquadest only, group II was treated with VCO-emulsion diet, and group III was treated with pure VCO diet. The contentof total cholesterol, HDL, LDL, and triacylglicerol were measured at theend of the treatment using enzymatic method. In this study, there weresome methods used for measurements: CHOD-PAP method for level oftotal cholesterol, PVS method for level of LDL cholesterol, CHOD-PAPmethod for level of HDL cholesterol, and GPO-PAP method for measuringlevel of triacylglicerol. The study results showed that diet of 0.945ml/daysof VCO and 3.78ml/days of VCO emulsion for 7 days significantlydecreased the level of total cholesterol and the level of LDL cholesterol,and increased the level of HDL cholesterol in the blood of Wistar mouse(α=0.05). Whereas it was shown that only by diet of VCO emulsion(α=0.05) decreased the level of triacylglicerol. Thus, VCO emulsionsignificantly lowered cholesterol in the experimental mouse better thanpure VCO diet only.</p><p>Key words : Virgin coconut oil(VCO) , VCO emulsion, lipid profile</p>

Sign in / Sign up

Export Citation Format

Share Document